v3.26.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2026
Accounting Policies [Abstract]  
Schedule of Reconciliation of Cash, Cash Equivalents and Restricted Cash
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Condensed Consolidated Balance Sheets to the total end of period cash, cash equivalents and restricted cash reported within the Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2026 and 2025:
(in thousands)September 30,
2026
September 30,
2025
Cash and cash equivalents$61,933 $70,022 
Restricted cash included in:
Prepaid expenses and other current assets— 103 
Non-current inventory and other365 366 
Total cash, cash equivalents and restricted cash$62,298 $70,491 
Schedule of Net Sales by Product
Net sales by product for the three and nine months ended September 30, 2026 and 2025 were as follows:
Three Months EndedNine Months Ended
(in thousands)September 30,
2026
September 30,
2025
September 30,
2026
September 30,
2025
Fanapt® net product sales
$38,765 $31,245 $104,314 $84,084 
HETLIOZ® net product sales
21,689 17,978 43,212 55,042 
PONVORY® net product sales
7,749 7,035 21,895 19,763 
NEREUSTM net product sales
1,612 — 2,641 — 
Total net product sales$69,815 $56,258 $172,062 $158,889